Indian pharma companies launch generic semaglutide injections for diabetes
New Delhi, March 21: Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity. The companies, namely Sun […]
